Step 1: VMA is the major end product of catecholamine (epinephrine and norepinephrine) breakdown and is excreted in urine.
Step 2: In pheochromocytoma (and neuroblastoma), tumour cells overproduce catecholamines, so their metabolism generates large amounts of VMA, raising urinary VMA. So the answer is pheochromocytoma.
Step 3: Urinary VMA is therefore a useful screening test for pheochromocytoma and for following neuroblastoma and ganglioneuroma.
Step 4: The distractors raise different metabolites: alkaptonuria raises homogentisic acid, phenylketonuria raises phenylpyruvate and phenyllactate, and diabetic ketoacidosis raises ketone bodies, none of which is VMA.